comparemela.com

Latest Breaking News On - Hunter gillies - Page 3 : comparemela.com

Hunter Gillies Sells 3,489 Shares of Aerovate Therapeutics, Inc (NASDAQ:AVTE) Stock

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Hunter Gillies sold 3,489 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $20.23, for a total value of $70,582.47. Following the transaction, the insider now directly owns 3,251 shares of the company’s stock, […]

Aerovate Therapeutics (NASDAQ:AVTE) Sees Large Volume Increase

Aerovate Therapeutics (NASDAQ:AVTE) Sees Large Volume Increase
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Silverarc Capital Management LLC Acquires New Holdings in Aerovate Therapeutics, Inc (NASDAQ:AVTE)

Silverarc Capital Management LLC Acquires New Holdings in Aerovate Therapeutics, Inc (NASDAQ:AVTE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Silverarc Capital Management LLC Makes New $1 36 Million Investment in Aerovate Therapeutics, Inc (NASDAQ:AVTE)

Silverarc Capital Management LLC Makes New $1 36 Million Investment in Aerovate Therapeutics, Inc (NASDAQ:AVTE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Aerovate Therapeutics (NASDAQ:AVTE) Trading 10 8% Higher

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares traded up 10.8% during mid-day trading on Thursday . The company traded as high as $21.34 and last traded at $21.32. 43,510 shares were traded during mid-day trading, a decline of 50% from the average session volume of 86,833 shares. The stock had previously closed at […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.